ContractBeta Test Agreement • May 5th, 2020 • Texas
Contract Type FiledMay 5th, 2020 Jurisdiction<DOCUMENT> <TYPE>EX-10.6 <SEQUENCE>15 <FILENAME>d15854exv10w6.txt <DESCRIPTION>BETA TEST AGREEMENT <TEXT> <PAGE> EXHIBIT 10.6 CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. BETA TEST AGREEMENT This Agreement is made effective as of the 1st day of March, 2001, between BioNumerik Pharmaceuticals, Inc., with a place of business at 8122 Datapoint Drive, Suite 1250, San Antonio, Texas 78229 ("BioNumerik"), and Cray Inc., with a place of business at 411 1st Avenue S. Suite 600, Seattle, WA 98104-2860 ("CRAY"). RECITALS: WHEREAS BioNumerik and a predecessor of CRAY entered into a Beta Test Agreement, dated as of August 18, 1994, as amended. WHEREAS, BioNumerik and CRAY wish to amend and restate the Beta Test Agreement to add Cray as a party and provide for the use and evaluation of computer systems and software and the provision of certain services different from thos